You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FluLaval

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (PNEUMOVAX 23, Fluarix, FluLaval)

Recruiting
  • Lymphoma
  • PNEUMOVAX 23
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Safety, Adverse Event Following Immunisation, Birth Outcomes Trial in Boston, Durham, Cincinnati (Quadrivalent Recombinant

Completed
Has Results
  • Safety
  • +2 more
  • Quadrivalent Recombinant Influenza Vaccine
  • Quadrivalent Inactivated Influenza Vaccine
  • Boston, Massachusetts
  • +2 more
Jan 9, 2023

Gonorrhea Male Trial in Chapel Hill (Cefixime, Ceftriaxone, Ciprofloxacin)

Recruiting
  • Gonorrhea Male
  • Chapel Hill, North Carolina
    Clinical and Translational Research Center (CTRC) at University
May 19, 2022

Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent

Completed
Has Results
  • Influenza
  • Data collection
  • Wilmington, North Carolina
    GSK Investigational Site
May 28, 2020

Qualitative, Qualitative, and Functional Studies Over First Year

Completed
  • Astrocytoma
  • +2 more
  • Hepatitis A Vaccine
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Oct 28, 2021

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Canada, United States (15 µg/strain of Quadrivalent

Completed
  • Virus Diseases
  • +3 more
  • 15 µg/strain of Quadrivalent VLP Vaccine
  • +2 more
  • Hollywood, Florida
  • +8 more
Jun 8, 2020

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Canada, United States (30 µg/strain of Quadrivalent

Completed
  • Virus Diseases
  • +3 more
  • 30 µg/strain of Quadrivalent VLP Vaccine
  • +3 more
  • Redding, California
  • +14 more
Oct 23, 2019

National Vaccine Adverse Event Reporting Survey and Etiology

Recruiting
  • COVID-19
  • +12 more
  • vaccinated
  • Northglenn, Colorado
    Neuroganics LLC
Mar 3, 2022

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser

Active, not recruiting
  • Influenza
  • +5 more
  • Flublok Quadrivalent
  • Standard Dose Inactivated Influenza Vaccine (SD-IIV)
  • Oakland, California
    Kaiser Permanente Northern California (entire region)
Feb 14, 2022

Influenza Trial in Canada, Mexico, United States (Quadrivalent seasonal influenza vaccine GSK2282512A, FluLavalTM-VB,

Completed
Has Results
  • Influenza
  • Quadrivalent seasonal influenza vaccine GSK2282512A
  • +2 more
  • Mesa, Arizona
  • +11 more
Aug 22, 2018

Psychology, Social, Inflammation, Defeat, Social Trial in Chapel Hill (Influenza vaccine, Placebo)

Recruiting
  • Psychology, Social
  • +3 more
  • Influenza vaccine
  • Placebo
  • Chapel Hill, North Carolina
  • +1 more
Dec 8, 2022

Influenza Trial in Sherbrooke (FLULAVAL® QUADRIVALENT)

Completed
Has Results
  • Influenza
  • FLULAVAL® QUADRIVALENT
  • Sherbrooke, Quebec, Canada
    GSK Investigational Site
Aug 9, 2018

Egg Allergy, Eligible for Vaccination Against Influenza Trial in Washington (FluMist intranasal influenza vaccine, Intramuscular

Completed
  • Egg Allergy
  • Eligible for Vaccination Against Influenza
  • FluMist intranasal influenza vaccine
  • Intramuscular influenza injection ("flu shot")
  • Washington, District of Columbia
    Walter Reed Army Medical Center
Oct 1, 2018

Influenza Trial in Milford, Salisbury, Winston-Salem (GSK Biologicals' FluLaval®, Placebo (saline), GSK Biologicals'

Completed
Has Results
  • Influenza
  • GSK Biologicals' FluLaval®
  • +3 more
  • Milford, Massachusetts
  • +2 more
Jul 4, 2018

Influenza Trial in Worldwide (FluLaval® Quadrivalent, Havrix™)

Completed
Has Results
  • Influenza
  • FluLaval® Quadrivalent
  • Havrix™
  • Dhaka, Bangladesh
  • +11 more
Jul 4, 2018

Influenza Trial in United States (FluLaval® Quadrivalent, Fluzone®)

Completed
Has Results
  • Influenza
  • FluLaval® Quadrivalent
  • Fluzone®
  • Sacramento, California
  • +11 more
Aug 9, 2018

Immune Response Trial in Worcester (Flulaval, Fluvirin, Fluzone)

Completed
Has Results
  • Immune Response
  • Flulaval
  • +4 more
  • Worcester, Massachusetts
    University of Massachusetts Medical School
Oct 17, 2017

Influenza Trial in Gent (FluLaval® TF)

Completed
  • Influenza
  • FluLaval® TF
  • Gent, Belgium
    GSK Investigational Site
May 5, 2017

Influenza Trial in United States (GSK investigational vaccine GSK1557482A, Fluzone®)

Completed
Has Results
  • Influenza
  • GSK investigational vaccine GSK1557482A
  • Fluzone®
  • Birmingham, Alabama
  • +27 more
Aug 22, 2018

Influenza Trial in Canada, United States (GSK2340274A, GSK2340273A, Seasonal trivalent influenza vaccine (TIV))

Completed
Has Results
  • Influenza
  • GSK2340274A
  • +3 more
  • Stockbridge, Georgia
  • +6 more
Jul 4, 2018

Influenza Trial in Mexico, United States (FluLaval™ Quadrivalent, Fluzone® Quadrivalent)

Completed
Has Results
  • Influenza
  • FluLaval™ Quadrivalent
  • Fluzone® Quadrivalent
  • Birmingham, Alabama
  • +65 more
Aug 9, 2018

Influenza, Human Trial run by the NIAID (VRC-FLUDNA047-00-VP, Flulaval (Registered) Seasonal Influenza Vaccine)

Completed
  • Influenza, Human
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Influenza Trial in United States (Influenza vaccine (A/H3N2, A/H1N1, and B strains), Fluarix)

Completed
  • Influenza
  • Influenza vaccine (A/H3N2, A/H1N1, and B strains)
  • Fluarix
  • Miami, Florida
  • +5 more
Oct 6, 2016

FluLaval® Quadrivalent Pregnancy Registry

Withdrawn
  • Influenza
  • Data collection
  • (no location specified)
Oct 23, 2014